Abbott Laboratories (ABT) Minority Interest (2009 - 2026)

Abbott Laboratories (ABT) has 18 years of Minority Interest data on file, last reported at $640.0 million in Q1 2026.

• For the quarter ending Q1 2026, Minority Interest rose 152.96% year-over-year to $640.0 million; the trailing twelve-month figure through Mar 2026 stood at $640.0 million (up 152.96% YoY), and the FY2025 full-year result was $641.0 million, up 170.46% from the prior year.
• Minority Interest steadied at $640.0 million in Q1 2026, from $641.0 million in the prior quarter.
• In the past five years, Minority Interest ranged from a high of $641.0 million in Q4 2025 to a low of $209.0 million in Q3 2022.
• A 5-year average of $283.8 million and a median of $232.0 million in 2024 frame the typical range for Minority Interest.
• Across the five-year window, Minority Interest decreased 3.48% in 2023 and jumped 170.46% in 2025, its largest moves.
• Tracing ABT's Minority Interest over 5 years: stood at $219.0 million in 2022, then grew by 2.28% to $224.0 million in 2023, then advanced by 5.8% to $237.0 million in 2024, then jumped by 170.46% to $641.0 million in 2025, then slipped by 0.16% to $640.0 million in 2026.
• Business Quant data shows ABT's Minority Interest at $640.0 million in Q1 2026, $641.0 million in Q4 2025, and $310.0 million in Q3 2025.